ethanolamine has been researched along with Idiopathic Pulmonary Fibrosis in 1 studies
Idiopathic Pulmonary Fibrosis: A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pei, X | 1 |
| Zheng, F | 1 |
| Li, Y | 1 |
| Lin, Z | 1 |
| Han, X | 1 |
| Feng, Y | 1 |
| Tian, Z | 1 |
| Ren, D | 1 |
| Cao, K | 1 |
| Li, C | 1 |
1 other study available for ethanolamine and Idiopathic Pulmonary Fibrosis
| Article | Year |
|---|---|
Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway.
Topics: Animals; Bleomycin; Ethanolamine; Hydroxyproline; Idiopathic Pulmonary Fibrosis; Mechanistic Target | 2022 |